16:21 IST
NSE
Preferential Issue
Suven Life Sciences Preferential Issue
Suven's monitoring agency report covers its Rs 857.64 Crore preferential warrant proceeds for the quarter ended September 2026. Shareholders approved reallocation of objects on August 25, 2026.
- Value
- ₹857.6 Cr